Table of Contents

2019-2024 Global Pneumococcal Vaccine Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pneumococcal Vaccine Consumption 2014-2024
2.1.2 Pneumococcal Vaccine Consumption CAGR by Region
2.2 Pneumococcal Vaccine Segment by Type
2.2.1 PPSV 23
2.2.2 PCV 7/13
2.2.3 PCV 10
2.3 Pneumococcal Vaccine Consumption by Type
2.3.1 Global Pneumococcal Vaccine Consumption Market Share by Type (2014-2019)
2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2014-2019)
2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2014-2019)
2.4 Pneumococcal Vaccine Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Vaccine Consumption by Application
2.5.1 Global Pneumococcal Vaccine Consumption Market Share by Application (2014-2019)
2.5.2 Global Pneumococcal Vaccine Value and Market Share by Application (2014-2019)
2.5.3 Global Pneumococcal Vaccine Sale Price by Application (2014-2019)

3 Global Pneumococcal Vaccine by Players
3.1 Global Pneumococcal Vaccine Sales Market Share by Players
3.1.1 Global Pneumococcal Vaccine Sales by Players (2017-2019)
3.1.2 Global Pneumococcal Vaccine Sales Market Share by Players (2017-2019)
3.2 Global Pneumococcal Vaccine Revenue Market Share by Players
3.2.1 Global Pneumococcal Vaccine Revenue by Players (2017-2019)
3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Players (2017-2019)
3.3 Global Pneumococcal Vaccine Sale Price by Players
3.4 Global Pneumococcal Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Pneumococcal Vaccine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Pneumococcal Vaccine by Regions
4.1 Pneumococcal Vaccine by Regions
4.1.1 Global Pneumococcal Vaccine Consumption by Regions
4.1.2 Global Pneumococcal Vaccine Value by Regions
4.2 Americas Pneumococcal Vaccine Consumption Growth
4.3 APAC Pneumococcal Vaccine Consumption Growth
4.4 Europe Pneumococcal Vaccine Consumption Growth
4.5 Middle East & Africa Pneumococcal Vaccine Consumption Growth

5 Americas
5.1 Americas Pneumococcal Vaccine Consumption by Countries
5.1.1 Americas Pneumococcal Vaccine Consumption by Countries (2014-2019)
5.1.2 Americas Pneumococcal Vaccine Value by Countries (2014-2019)
5.2 Americas Pneumococcal Vaccine Consumption by Type
5.3 Americas Pneumococcal Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Pneumococcal Vaccine Consumption by Countries
6.1.1 APAC Pneumococcal Vaccine Consumption by Countries (2014-2019)
6.1.2 APAC Pneumococcal Vaccine Value by Countries (2014-2019)
6.2 APAC Pneumococcal Vaccine Consumption by Type
6.3 APAC Pneumococcal Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Pneumococcal Vaccine by Countries
7.1.1 Europe Pneumococcal Vaccine Consumption by Countries (2014-2019)
7.1.2 Europe Pneumococcal Vaccine Value by Countries (2014-2019)
7.2 Europe Pneumococcal Vaccine Consumption by Type
7.3 Europe Pneumococcal Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Pneumococcal Vaccine by Countries
8.1.1 Middle East & Africa Pneumococcal Vaccine Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Pneumococcal Vaccine Value by Countries (2014-2019)
8.2 Middle East & Africa Pneumococcal Vaccine Consumption by Type
8.3 Middle East & Africa Pneumococcal Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pneumococcal Vaccine Distributors
10.3 Pneumococcal Vaccine Customer

11 Global Pneumococcal Vaccine Market Forecast
11.1 Global Pneumococcal Vaccine Consumption Forecast (2019-2024)
11.2 Global Pneumococcal Vaccine Forecast by Regions
11.2.1 Global Pneumococcal Vaccine Forecast by Regions (2019-2024)
11.2.2 Global Pneumococcal Vaccine Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pneumococcal Vaccine Forecast by Type
11.8 Global Pneumococcal Vaccine Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Details
12.1.2 Pneumococcal Vaccine Product Offered
12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Pfizer News
12.2 GSK
12.2.1 Company Details
12.2.2 Pneumococcal Vaccine Product Offered
12.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 GSK News
12.3 MSD
12.3.1 Company Details
12.3.2 Pneumococcal Vaccine Product Offered
12.3.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 MSD News
12.4 Sanofipasteur
12.4.1 Company Details
12.4.2 Pneumococcal Vaccine Product Offered
12.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Sanofipasteur News
12.5 CDIBP
12.5.1 Company Details
12.5.2 Pneumococcal Vaccine Product Offered
12.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 CDIBP News
...

13 Research Findings and Conclusion